Published by Iain Gilbert on 30th January 2026
(Sharecast News) - Drugmaker Astrazeneca said on Friday that it has expanded its weight‑management pipeline after striking a strategic collaboration with CSPC Pharmaceuticals to develop a series of next‑generation obesity and type‑2 diabetes therapies.
URL: http://www.digitallook.com/dl/news/story/35666002/...